The Effect of Pseudomonas aeruginosa Infection on Clinical Parameters in Steady-State Bronchiectasis

This publication has 10 references indexed in Scilit:

• Revisited Physicochemical and Transport Properties of Respiratory Mucus in Genotyped Cystic Fibrosis Patients
  American Journal of Respiratory and Critical Care Medicine, 1997
• Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa
  European Respiratory Journal, 1996
• Changing patterns of susceptibilities of blood, urinary and respiratory pathogens in Hong Kong
  Journal of Hospital Infection, 1995
• Clinical, Pathophysiologic, and Microbiologic Characterization of Bronchiectasis in an Aging Cohort
  Chest, 1995
• Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis
  Journal of Antimicrobial Chemotherapy, 1994
• Sputum and serum pharmacokinetics of loracarbef (LY163892) in patients with chronic bronchial sepsis
  Journal of Antimicrobial Chemotherapy, 1994
• Role of Chronic Pseudomonas aeruginosa Infection in the Development of Bronchiectasis
  Chest, 1992
• Ofloxacin compared with amoxycillin in treating infective exacerbations in bronchiectasis
  Respiratory Medicine, 1989
• Simple method of monitoring colonising microbial load in chronic bronchial sepsis: pilot comparison of reduction in colonising microbial load with antibiotics given intermittently and continuously.
  Journal of Clinical Pathology, 1987
• Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation.
  Thorax, 1986